Picture of Blackmores logo

BKL — Blackmores Share Price

0.000.00%
au flag iconLast trade - 00:00
Consumer DefensivesBalancedMid CapNeutral

Momentum

Relative Strength (%)
1m-6.18%
3m-14.15%
6m+11.25%
1yr+10.79%
Volume Change (%)
10d/3m-22.68%
Price vs... (%)
52w High-19.66%
50d MA-8.06%
200d MA+0.03%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)33.87
PEG Ratio (f)0.96
EPS Growth (f)54.49%
Dividend Yield (f)1.48%
Valuation (ttm)IndustryMarket
Price to Book Value4.33
Price to Tang. Book5.38
Price to Free Cashflow40.42
Price to Sales2.81
EV to EBITDA22.07

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital11%
Return on Equity7.13%
Operating Margin7.95%

Financial Summary

Year End 30th JunUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueAU$m552.16601.14588.91568.35575.92646.76735.44-4.32%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-41+25.97-31.74-85.97+179.45+69.49+47.58n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202230th Jun 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Blackmores EPS forecast chart

Profile Summary

Blackmores Limited is an Australia-based natural healthcare company. The Company is engaged in developing, manufacturing, sales, and marketing of natural health products for humans and animals including vitamins, and herbal and mineral nutritional supplements. The Company's segments include Australia and New Zealand (ANZ), China, International. ANZ segment includes BioCeuticals and PAW brands sold across Australia and New Zealand. China segment consists of Blackmores and PAW by Blackmores brands in China and China Export Division. The International segment comprises of Indonesia, Thailand, Malaysia, Singapore, Hong Kong (China), Taiwan (China), Korea, Vietnam, Pakistan, and Kazakhstan.

Directors

Last Annual
June 30th, 2021
Last Interim
June 30th, 2021
Incorporated
February 1st, 1962
Public Since
May 2nd, 1985
No. of Shareholders
15,713
No. of Employees
1,200
Sector
Food & Tobacco
Industry
Consumer Defensives
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
19,365,519

BKL Share Price Performance

FAQ

Or unlock with your email

Or unlock with your email